Celgene CorporationJacqualyn A. Fouse, Ph.D, 908-673-9956EVP, Chief Financial OfficerorPatrick E. Flanigan III, 908-673-9969VP, Investor Relations
today announced its presentation at the 31 Annual J.P. Morgan Healthcare Conference on January 7, 2013 at 11:00a.m. E.T. will be webcast live and will be available in the investor relations section of the company’s Web site at . Celgene management will provide an overview of the company.
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit the company’s Web site at .